Novo CEO pressed by Senate to chop rates of being overweight, diabetes medicines CEO Lars Fruergaard Jørgensen instructed lawmakers the company would think about new talks with insurers in regards to the record price ranges of Wegovy and copyright if they pledge to help keep the medicines on their formularies. https://keeganbbaaz.aboutyoublog.com/32431069/healthcare-news-an-overview